Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Ophthotech Corp (NASDAQ:OPHT)

2.63
Delayed Data
As of Jun 28
 -0.07 / -2.59%
Today’s Change
2.24
Today|||52-Week Range
65.96
-45.55%
Year-to-Date

Today’s Trading

Previous close2.70
Today’s open2.74
Day’s range2.60 - 2.78
Volume619,448
Average volume (3 months)957,333
Market cap$96.8M
Dividend yield--
Data as of 06/28/2017

Growth & Valuation

Earnings growth (last year)-78.10%
Earnings growth (this year)+27.85%
Earnings growth (next 5 years)--
Revenue growth (last year)-1.16%
P/E ratioNM
Price/Sales3.37
Price/Book--

Competitors

 Today’s
change
Today’s
% change
ZFGNZafgen Inc+0.12+3.39%
AGTCApplied Genetic Tech...-0.20-3.70%
MRTXMirati Therapeutics ...-0.10-2.67%
ACRXAcelRx Pharmaceutica...+0.05+2.44%
Data as of 06/28/2017

Financials

Next reporting dateAugust 9, 2017
EPS forecast (this quarter)-$1.06
Annual revenue (last year)$50.9M
Annual profit (last year)-$193.4M
Net profit margin-379.93%

Profile

Sector
Health Technology
Industry
Biotechnology
Chairman &
Chief Executive Officer
David R. Guyer
President
Glenn P. Sblendorio
Corporate headquarters
New York, New York

Forecasts